Opus Genetics, Inc. (FRA:R3X1)
2.350
+0.015 (0.64%)
Last updated: Jan 28, 2026, 5:00 PM CET
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of €134.09 million as of January 30, 2026. Its market cap has increased by 273.54% in one year.
Market Cap
134.09M
Enterprise Value
109.05M
Revenue
12.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.35
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from 17.89M to 134.09M, an increase of 649.69%. That is a compound annual growth rate of 46.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 134.09M | 13.58% |
| Dec 31, 2025 | 118.06M | 225.37% |
| Dec 31, 2024 | 36.29M | -41.14% |
| Dec 29, 2023 | 61.65M | -10.30% |
| Dec 30, 2022 | 68.73M | 21.12% |
| Dec 31, 2021 | 56.74M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADM Hamburg Aktiengesellschaft | 173.72M |
| Deutsche Real Estate AG | 172.89M |
| Greenland Resources | 158.17M |
| 029 Group SE | 156.00M |
| LEWAG Holding Aktiengesellschaft | 134.01M |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 129.06M |
| Sparta AG | 125.60M |
| CeoTronics AG | 124.49M |